Clinical trial
Ticagrelor Versus Cilostazol in Ischemic Stroke
NCT06196047 is registered in ClinicalTrials.gov with Kafrelsheikh University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Ticagrelor Versus Cilostazol in Ischemic Stroke
- Lead sponsor
- Kafrelsheikh University
- Phase
- Phase 3
- Overall status
- Recruiting
- Start date
- December 1, 2023
- Completion date
- December 30, 2024
- Enrollment
- 900 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.